Tumor-Associated CD204-Positive Macrophage Is a Prognostic Marker in Clinical Stage I Lung Adenocarcinoma

Figure 3

Kaplan-Meier analysis of disease-free survival (a) and overall survival (b) of patients with lung adenocarcinoma according to CD204+ macrophage density.

(a)

(b)